Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Human cell types important for Hepatitis C Virus replication in vivo and in vitro. Old assertions and current evidence
2011
Effect of preventive zinc supplementation on linear growth in children under 5 years of age in developing countries: a meta-analysis of studies for input to the lives saved tool
2011
Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy
2007
Prospective Comparison of Spleen and Liver Stiffness by Using Shear-Wave and Transient Elastography for Detection of Portal Hypertension in Cirrhosis
2014
A Plant-Derived Flavonoid Inhibits Entry of All HCV Genotypes Into Human Hepatocytes
2012
Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference
2006
Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
2010
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Hepatocellular carcinoma
2018 Standout
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
2010
Zinc and immune function: the biological basis of altered resistance to infection
1998
Now there are many (stages) where before there was one
2009
Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting
2011
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials
1999
Preventive Zinc Supplementation among Infants, Preschoolers, and Older Prepubertal Children
2009
Effect of daily zinc supplementation on child mortality in southern Nepal: a community-based, cluster randomised, placebo-controlled trial
2007
The Impact of IL28B Genetic Variants on Recurrent Hepatitis C in Liver Transplantation: Significant Lessons from a Dual Graft Case
2011
Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
2008
Hepatic Fibrosis: Prospective Comparison of MR Elastography and US Shear-Wave Elastography for Evaluation
2014
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Liver biopsy†
2008
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
2007
Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
2012
Expanding consensus in portal hypertension
2015 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
2009
Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients
2018
The Course of Posttransplant Hepatitis C Infection
2012
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Non invasive evaluation of portal hypertension using transient elastography
2011
Portal hypertensive bleeding in cirrhosis
2016 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Methods of assessment of iodine status in humans: a systematic review
2009 Standout
Evolving challenges in hepatic fibrosis
2010
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Liver transplantation and hepatitis C
2011
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control
2016
American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases
2017
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Effect of zinc supplementation on mortality in children aged 1–48 months: a community-based randomised placebo-controlled trial
2007
Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of Recurrence
2011
Where and why are 10 million children dying every year?
2003 Standout
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡
2007
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Noninvasive assessment of liver fibrosis
2010
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Naturally occurring genotype 2b/1a hepatitis C virus in the United States
2011
What works? Interventions for maternal and child undernutrition and survival
2008 Standout
Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications
2007
Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
2008
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics
2010
miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence
2017 StandoutNobel
NAFLD: A multisystem disease
2015 Standout
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C
2009
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: a meta-analysis of randomized controlled trials
2002
Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis
2017
Replication of hepatitis C virus
2007 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Expression of MicroRNA miR-122 Facilitates an Efficient Replication in Nonhepatic Cells upon Infection with Hepatitis C Virus
2012
Increased Risk of Severe Hepatitis C Virus Recurrence After Liver Transplantation in Patients With a T Allele of IL28B rs12979860
2012
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Interferon-Free Regimens in the Liver-Transplant Setting
2014
Role of Zinc Administration in Prevention of Childhood Diarrhea and Respiratory Illnesses: A Meta-analysis
2007
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Substantial Reduction in Severe Diarrheal Morbidity by Daily Zinc Supplementation in Young North Indian Children
2002
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals
2017
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Viral Quasispecies Evolution
2012
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Works of J.A. Carrión being referenced
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation
2006
Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C
2014
Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection
2006
Donor and Recipient IL28B Polymorphisms in HCV-Infected Patients Undergoing Antiviral Therapy before and after Liver Transplantation
2011
Serum Fibrosis Markers Identify Patients With Mild and Progressive Hepatitis C Recurrence After Liver Transplantation
2009
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
2006
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study
2008
Hepatitis C Virus Compartmentalization and Infection Recurrence after Liver Transplantation
2009
Retransplantation in patients with hepatitis C recurrence after liver transplantation
2010
Liver Stiffness Identifies Two Different Patterns of Fibrosis Progression in Patients With Hepatitis C Virus Recurrence After Liver Transplantation
2009
Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains
2010
Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study
2007
Effects of short-term zinc supplementation on cellular immunity, respiratory symptoms, and growth of malnourished Equadorian children.
1996